ArticleFrontiers in immunology2025

Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment.

Dingxian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.